<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03387696</url>
  </required_header>
  <id_info>
    <org_study_id>ZygoRea (38RC17.008)</org_study_id>
    <nct_id>NCT03387696</nct_id>
  </id_info>
  <brief_title>Mucormycosis in ICU</brief_title>
  <acronym>ZygoRéa</acronym>
  <official_title>Mucormycosis in ICU: A French Multicenter Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Mucormycosis is an invasive fungal infection affecting patients with various clinical
      conditions especially patients with heavy immunosuppression or patients with trauma or
      extensive burns.

      ZygoRéa is a retrospective and multicentric French study aimed to evaluate survival of
      patients with mucormycosis admitted in ICU at day-28 after admission. This study will also
      try also to describe the epidemiology of patients admitted in ICU.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Mucormycosis is an invasive fungal infection affecting patients with various clinical
      conditions especially patients with heavy immunosuppression or patients with trauma or
      extensive burns. The incidence of Mucormycosis is currently increasing reaching 7% of
      invasive fungal infections in some immunocompromised patients. Because of its aggressive
      nature, Mucormycosis is associated with poor survival and high morbidity ; mortality is
      estimated between 16% and 64% according to different retrospective studies. No study has ever
      evaluated prognosis of patients with mucormycosis admitted in intensive care units (ICU).

      ZygoRéa is a retrospective and multicentric French study aimed to evaluate survival of
      patients with mucormycosis admitted in ICU at day-28 after admission. This study will also
      try also to describe the epidemiology of patients admitted in ICU and to evaluate the
      prognosis of different subgroups of patients according to :

        -  their clinical characteristics : demographic characteristics, clinical conditions and
           factors of immunosuppression

        -  the characteristics of the fungal infection

        -  the treatment strategy

        -  the severity of the initial illness, evaluated by severity scores

      Twenty-one French ICU are currently including more than 45 patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 8, 2017</start_date>
  <completion_date type="Anticipated">June 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality at Day 28</measure>
    <time_frame>up to 28 days</time_frame>
    <description>Mortality at Day 28 after ICU admission</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality at Day 90</measure>
    <time_frame>up to 90 days</time_frame>
    <description>Mortality at Day 90 after ICU admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality during the ICU stage</measure>
    <time_frame>up to 28 days</time_frame>
    <description>Mortality status (alive or dead) at the end of the ICU stage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length stay in ICU</measure>
    <time_frame>up to 28 days</time_frame>
    <description>number of days in intensive care Unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length stay of hospitalization</measure>
    <time_frame>up to 90 days</time_frame>
    <description>number of days in hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality during the hospitalization</measure>
    <time_frame>up to 90 days</time_frame>
    <description>Mortality status (alive or dead) at the end of the hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prognostic criteria</measure>
    <time_frame>up to 28 days</time_frame>
    <description>Prognostic factors of mortality in intensive care units</description>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Mucormycosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients with mycormycosis hospitalized in intensive care unit during the 2008-2016 period
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  confirmed or suspected mucormycosis, based on international definition from EORTC/MSG

          -  patient hospitalized in intensive care unit during the 2008-2016 period

          -  Zygomycosis identification in at least 2 solids organs or identification in
             hemoculture

        Exclusion Criteria:

          -  Age under 18 years old

          -  Patient under the law
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nicolas Terzi, Prof</last_name>
    <phone>0033476767109</phone>
    <email>nterzi@chu-grenoble.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cyrielle Clape, PhD</last_name>
    <phone>0033476767109</phone>
    <email>cclape@chu-grenoble.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Intensive Care Unit - Hospital Amiens</name>
      <address>
        <city>Amiens</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yoann Zerbib, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Intensive Care Unit - Hospital Angers</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Achille Kouatchet, MD</last_name>
    </contact>
    <investigator>
      <last_name>Pierre Asfar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Intensive Care Unit - Hospital Besançon</name>
      <address>
        <city>Besançon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gaël Piton, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Intensive Care Unit - Hospital Béthune</name>
      <address>
        <city>Béthune</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe Vinconneau, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Intensive Care Unit - Hospital Caen</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daubin, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Intensive Care Unit - Hospital Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lautrette, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Intensive Care Unit - Hospital Dijon</name>
      <address>
        <city>Dijon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre-Emmanuel Charles, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Intensive Care Unit - Hospital Grenoble Alpes</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johanna Claustre, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Intensive Care Unit - Hospital Lille</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nseir, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Intensive Care Unit - Hospital Lyon</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Argaud, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Intensive Care Unit - Hospital Montpellier</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Klouche, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Intensive Care Unit - Hospital Nantes</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Reignier, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Intensive Care Unit - Hospital l'Archet - Nice</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dellamonica, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Intensive Care Unit - Hospital Bichat</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonneville, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Intensive Care Unit - Hospital Saint Louis</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Virgine Lemiale, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Intensive Care Unit - Hospital Tenon</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guillaume Voiriot, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Intensive Care Unit - Hospital Poitiers</name>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rémi Coudroy, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Intensive Care Unit - Hospital Rennes</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Phelouzat, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Intensive Care Unit - Hospital Rouen</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tamion, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Intensive Care Unit - Hospital Saint Etienne</name>
      <address>
        <city>Saint-Étienne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Darmon, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Intensive Care Unit - Hospital Tours</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan Ehrmann, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 1, 2017</study_first_submitted>
  <study_first_submitted_qc>December 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">January 2, 2018</study_first_posted>
  <last_update_submitted>December 22, 2017</last_update_submitted>
  <last_update_submitted_qc>December 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">January 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mucormycosis</keyword>
  <keyword>Intensive Care Medicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mucormycosis</mesh_term>
    <mesh_term>Zygomycosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

